Parkman Healthcare Partners LLC Sells 172,529 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Parkman Healthcare Partners LLC reduced its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 38.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 277,471 shares of the company’s stock after selling 172,529 shares during the quarter. Parkman Healthcare Partners LLC’s holdings in LifeStance Health Group were worth $2,045,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of LFST. Jennison Associates LLC raised its holdings in LifeStance Health Group by 278.4% in the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company’s stock worth $59,597,000 after purchasing an additional 5,949,438 shares during the period. Dimensional Fund Advisors LP increased its stake in LifeStance Health Group by 87.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock worth $25,977,000 after buying an additional 1,643,390 shares in the last quarter. Vanguard Group Inc. increased its stake in LifeStance Health Group by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company’s stock worth $78,781,000 after buying an additional 784,818 shares in the last quarter. First Trust Advisors LP purchased a new stake in LifeStance Health Group in the 4th quarter worth $4,535,000. Finally, First Eagle Investment Management LLC increased its stake in LifeStance Health Group by 182.8% in the 4th quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company’s stock worth $5,790,000 after buying an additional 507,826 shares in the last quarter. 85.50% of the stock is owned by institutional investors.

Analysts Set New Price Targets

LFST has been the subject of a number of analyst reports. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. KeyCorp initiated coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 price target for the company. Finally, Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price target for the company. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $8.30.

LifeStance Health Group Price Performance

Shares of LFST opened at $5.87 on Wednesday. The firm has a market capitalization of $2.28 billion, a PE ratio of -22.58 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $8.61. The company’s fifty day moving average price is $6.62 and its 200-day moving average price is $7.24.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 3.20% of the stock is owned by corporate insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.